NL-OMON39237已完成不适用
Cardiac- and vascular disease (-abnormalities) as underlying cause of premature birth. - PRELHUDE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Women who deliver prematurely for unknown reasons
排除标准
- •HIV positive, patients with congenital heart disease, multiple pregnancies, uterine anomalies, congenital/chromosomal anomalies.
研究者
相似试验
尚未招募
不适用
Cardiovascular disease manifestations in COVID-19 patientsCTRI/2021/06/034065Dr Swati Datta
已完成
不适用
Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)JPRN-UMIN000000492agoya University160
已完成
不适用
ife-style related desease and cardiovascular disease studyife-style related diseaseJPRN-UMIN000002997Osaka University100
尚未招募
不适用
Cardiac Effects In Moderate ToSevere COVID-19 Patients Receiving Treatment InCritical Care Unit Of A Tertiary Care Hospital,West BengalCTRI/2021/06/034469MEDICAL COLLEGE KOLKATA
进行中（未招募）
不适用
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240